|
| 滋肾健骨方含药血清抑制HGHF诱导成骨细胞铁死亡机制 |
| Mechanism of Zishen Jiangu Formula-containing serum in the inhibition of HGHF-induced ferroptosis in osteoblasts |
| |
| DOI:10.3969/j.issn.1006-7108.2026.11.005 |
| 中文关键词: 滋肾健骨方含药血清 2型糖尿病性骨质疏松症 铁死亡 氧化应激 Nrf2/SLC7A11/GPX4 信号通路 |
| 英文关键词:Zishen Jiangu Formula-containing serum type 2 diabetic osteoporosis ferroptosis oxidative stress Nrf2/SLC7A11/GPX4 signaling pathway |
| 基金项目:广东医科大学临床+基础科技创新专项(GDMULCJC2024150);深圳市科技创新委员会研究项目(JCYJ20240813103617024;JCYJ202506041853040);深圳市宝安区区属公立医院高质量发展研究项目(BAGZL2024064) |
|
| 摘要点击次数: 73 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的 探究滋肾健骨方含药血清对高糖高脂(high glucose and high fat,HGHF)诱导小鼠颅顶成骨细胞 (MC3T3-E1)铁死亡的影响与作用机制。方法 采用细胞计数试剂盒(CCK-8)分别筛选HGHF及滋肾健骨方含药血清最佳干预浓度。以最佳浓度干预后,运用比色法检测丙二醛(MDA) 、谷胱甘肽(GSH)水平, 荧光探针DCFH-DA检测活性氧(ROS)水平;透射电子显微镜观察细胞线粒体超微结构变化;免疫印迹检测核因子红细胞2相关因子2(Nrf2)、溶质载体家族7成员11(SLC7A11)、谷胱甘肽过氧化物酶4(GPX4)、长链脂酰-CoA合成酶4(ACSL4)、铁蛋白重链1(FTH1)、Runt相关转录因子2?(RUNX2)、骨钙素(OCN)的蛋白表达;碱性磷酸酶(ALP)、茜素红S(ARS)染色及定量检测评价细胞成骨分化及矿化功能。结果 HGHF可诱导MC3T3-E1细胞铁死亡。与HGHF组比较,滋肾健骨方含药血清和铁死亡抑制剂 Ferrostatin-1(Fer-1)干预后,GSH水平以及Nrf2、SLC7A11、GPX4、FTH1蛋白表达显著升高(P<0.05),MDA水平、ROS水平以及ACSL4蛋白表达显著降低(P<0.05),且细胞成骨分化与矿化功能显著改善。加入Nrf2抑制剂ML385后,滋肾健骨方含药血清对HGHF处理后MC3T3-E1细胞的保护作用被部分逆转。结论 滋肾健骨方含药血清可抑制HGHF诱导的MC3T3-E1细胞铁死亡,其机制可能与激活Nrf2/SLC7A11/GPX4信号通路相关。 |
| 英文摘要: |
| Objective To investigate the effect and underlying mechanism of Zishen Jiangu Formula-containing serum on ferroptosis in mouse calvarial osteoblasts (MC3T3-E1) induced by high glucose and high fat (HGHF). Methods The optimal intervention concentrations of HGHF and Zishen Jiangu Formula-containing serum were screened using Cell Counting Kit-8 (CCK-8) assay. After intervention with the optimal concentration, the levels of malondialdehyde (MDA) and glutathione (GSH) were detected with colorimetry. The level of reactive oxygen species (ROS) was measured with fluorescent probe DCFH-DA. The changes of mitochondrial ultrastructure in cells were observed under transmission electron microscope. The protein expressions of nuclear factor erythroid 2-related factor 2 (Nrf2), solute carrier family 7 member 11 (SLC7A11), glutathione peroxidase 4 (GPX4), long-chain acyl-CoA synthetase 4 (ACSL4), ferritin heavy chain 1 (FTH1), Runt-related transcription factor 2 (RUNX2), and osteocalcin (OCN) were detected with Western blotting. Alkaline phosphatase (ALP) staining and Alizarin red S (ARS) staining combined with quantitative analysis were used to evaluate the osteogenic differentiation and mineralization of cells. Results HGHF induced ferroptosis in MC3T3-E1 cells. Compared with the HGHF group, after intervention with Zishen Jiangu Formula-containing serum and ferroptosis inhibitor Ferrostatin-1 (Fer-1), the GSH level and the protein expressions of Nrf2, SLC7A11, GPX4, and FTH1 increased significantly (P<0.05). MDA level, ROS level, and ACSL4 protein expression decreased significantly (P<0.05). The osteogenic function of cells were obviously improved. After the addition of Nrf2 inhibitor ML385, the protective effect of Zishen Jiangu Formula-containing serum on HGHF-treated MC3T3-E1 cells was partially reversed. Conclusion Zishen Jiangu Formula-containing serum inhibits HGHF-induced ferroptosis in MC3T3-E1 cells. Its mechanism may be related to the activation of the Nrf2/SLC7A11/GPX4 signaling pathway. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|